These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22927922)

  • 1. Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease.
    Rossi F; Bellini G; Alisi A; Alterio A; Maione S; Perrone L; Locatelli F; Miraglia del Giudice E; Nobili V
    PLoS One; 2012; 7(8):e42259. PubMed ID: 22927922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cannabinoid receptor type 2 Q63R variant increases the risk of celiac disease: implication for a novel molecular biomarker and future therapeutic intervention.
    Rossi F; Bellini G; Tolone C; Luongo L; Mancusi S; Papparella A; Sturgeon C; Fasano A; Nobili B; Perrone L; Maione S; del Giudice EM
    Pharmacol Res; 2012 Jul; 66(1):88-94. PubMed ID: 22465144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.
    Auguet T; Berlanga A; Guiu-Jurado E; Terra X; Martinez S; Aguilar C; Filiu E; Alibalic A; Sabench F; Hernández M; Del Castillo D; Richart C
    Biomed Res Int; 2014; 2014():502542. PubMed ID: 24864249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-ethnic study of a PNPLA3 gene variant and its association with disease severity in non-alcoholic fatty liver disease.
    Zain SM; Mohamed R; Mahadeva S; Cheah PL; Rampal S; Basu RC; Mohamed Z
    Hum Genet; 2012 Jul; 131(7):1145-52. PubMed ID: 22258181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease.
    Strisciuglio C; Bellini G; Miele E; Martinelli M; Cenni S; Tortora C; Tolone C; Miraglia Del Giudice E; Rossi F
    J Clin Gastroenterol; 2018; 52(5):e37-e43. PubMed ID: 27875353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis.
    Bellini G; Olivieri AN; Grandone A; Alessio M; Gicchino MF; Nobili B; Perrone L; Maione S; del Giudice EM; Rossi F
    Scand J Rheumatol; 2015; 44(4):284-7. PubMed ID: 25974389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking.
    Rastegar M; Samadizadeh S; Yasaghi M; Moradi A; Tabarraei A; Salimi V; Tahamtan A
    Arch Virol; 2021 Nov; 166(11):3117-3126. PubMed ID: 34514519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease.
    Mendez-Sanchez N; Zamora-Valdes D; Pichardo-Bahena R; Barredo-Prieto B; Ponciano-Rodriguez G; Bermejo-Martínez L; Chavez-Tapia NC; Baptista-González HA; Uribe M
    Liver Int; 2007 Mar; 27(2):215-9. PubMed ID: 17311616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No association between the functional cannabinoid receptor type 2 Q63R variants and inflammatory bowel disease in Turkish subjects.
    Yonal O; Eren F; Yılmaz Y; Atuğ Ö; Över HH
    Turk J Gastroenterol; 2014 Dec; 25(6):639-43. PubMed ID: 25599774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche.
    Bellini G; Grandone A; Torella M; Miraglia del Giudice E; Nobili B; Perrone L; Maione S; Rossi F
    PLoS One; 2015; 10(10):e0140142. PubMed ID: 26447698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.
    Rotman Y; Koh C; Zmuda JM; Kleiner DE; Liang TJ;
    Hepatology; 2010 Sep; 52(3):894-903. PubMed ID: 20684021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver.
    Valenti L; Nobili V; Al-Serri A; Rametta R; Leathart JB; Zappa MA; Dongiovanni P; Fracanzani AL; Alterio A; Roviaro G; Daly AK; Fargion S; Day CP
    J Hepatol; 2011 Dec; 55(6):1409-14. PubMed ID: 21777557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice.
    Tahamtan A; Samieipoor Y; Nayeri FS; Rahbarimanesh AA; Izadi A; Rashidi-Nezhad A; Tavakoli-Yaraki M; Farahmand M; Bont L; Shokri F; Mokhatri-Azad T; Salimi V
    Virulence; 2018 Jan; 9(1):217-230. PubMed ID: 28992427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of cannabinoid receptor 2 Q63R gene polymorphism in Lebanese patients with rheumatoid arthritis.
    Ismail M; Khawaja G
    Clin Rheumatol; 2018 Nov; 37(11):2933-2938. PubMed ID: 30032418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid Receptor 2 as Antiobesity Target: Inflammation, Fat Storage, and Browning Modulation.
    Rossi F; Bellini G; Luongo L; Manzo I; Tolone S; Tortora C; Bernardo ME; Grandone A; Conforti A; Docimo L; Nobili B; Perrone L; Locatelli F; Maione S; Del Giudice EM
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3469-78. PubMed ID: 27294325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects.
    Tahamtan A; Rezaiy S; Samadizadeh S; Moradi A; Tabarraei A; Javid N; Oladnabi M; Naeimi MH
    J Mol Neurosci; 2020 Jan; 70(1):26-31. PubMed ID: 31407233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway.
    Denaës T; Lodder J; Chobert MN; Ruiz I; Pawlotsky JM; Lotersztajn S; Teixeira-Clerc F
    Sci Rep; 2016 Jun; 6():28806. PubMed ID: 27346657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.
    Coppola N; Zampino R; Bellini G; Macera M; Marrone A; Pisaturo M; Boemio A; Nobili B; Pasquale G; Maione S; Adinolfi LE; Perrone L; Sagnelli E; Miraglia Del Giudice E; Rossi F
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):334-40. PubMed ID: 23707465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease.
    Tang Y; Bian Z; Zhao L; Liu Y; Liang S; Wang Q; Han X; Peng Y; Chen X; Shen L; Qiu D; Li Z; Ma X
    Clin Exp Immunol; 2011 Nov; 166(2):281-90. PubMed ID: 21985374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evidence that the cannabinoid receptor 2-63 RR variant is associated with the acquisition and/or expansion of HIV infection.
    Sagnelli C; Uberti-Foppa C; Hasson H; Bellini G; Minichini C; Salpietro S; Messina E; Barbanotti D; Merli M; Punzo F; Coppola N; Lazzarin A; Sagnelli E; Rossi F
    HIV Med; 2018 Oct; 19(9):597-604. PubMed ID: 29932291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.